Researchers reveal SARS-CoV-2 distribution and relation to tissue damage in patients

covid
Credit: Pixabay/CC0 Public Domain

Researchers have mapped the distribution of SARS-CoV-2, the virus that causes COVID-19, in deceased patients with the disease, and shed new light on how viral load relates to tissue damage.

Their study of 11 autopsy cases, published today in eLife, may contribute to our understanding of how COVID-19 develops in the body following infection.

More than 24 million SARS-CoV-2 infections have been reported to date, and the number of deaths attributed to COVID-19 has exceeded 828,000 worldwide. COVID-19 occurs with varying degrees of severity. While most patients have mild symptoms, some experience more severe symptoms and may need to be hospitalized. A minority of those in hospital may enter a , with respiratory failure, blood vessel complications, or multiple .

"Clinical observations suggest that COVID-19 is a systemic disease, meaning that it affects the entire body rather than just a single organ such as the lungs," explains co-first author Stefanie Deinhardt-Emmer, Resident in Medical Microbiology, Jena University Hospital, Jena, Germany. "But we don't currently have a clear understanding of disease development in humans and other organisms, due to the lack of appropriate experimental models. Investigating the viral distribution of SARS-CoV-2 within the and how this relates to tissue damage would help us address this gap."

To do this, Deinhardt-Emmer and colleagues studied 11 autopsy cases of patients with COVID-19. They performed the autopsies at the early postmortem stage to minimize bias due to the degradation of tissues and viral ribonucleic acid (RNA—a molecule similar to DNA).

Their analysis revealed high viral loads in most of the patients' lungs, which had caused significant damage to those organs. Using an imaging technique called , the team also visualized intact viral particles in the .

"Interestingly, we also detected SARS-CoV-2 RNA throughout various other tissues and organs unrelated to the lungs that did not cause visible tissue damage," says co-first author Daniel Wittschieber, Senior Forensic Pathologist at Jena University Hospital. The researchers say that this distribution of viral RNA throughout the body supports the idea that our is unable to respond adequately to the virus' presence in the blood.

"We show that COVID-19 is a systemic disease as determined by the presence of virus RNA, and yet unrelated to outside the lungs," says co-senior author Bettina Löffler, Director of the Institute for Medical Microbiology, Jena University Hospital. "To our knowledge, this study is the only one to date that has measured viral loads in a wide variety of organs and tissues, with more than 60 samples studied per patient."

"The insights gathered from our work may add to our understanding of how COVID-19 develops in the body following infection," concludes co-senior author Gita Mall, Head of the Institute of Forensic Medicine, Jena University Hospital.


Explore further

Study uncovers two phases of infection in patients with severe COVID-19 pneumonia

More information: Stefanie Deinhardt-Emmer et al, Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage, eLife (2021). DOI: 10.7554/eLife.60361
Journal information: eLife

Provided by eLife
Citation: Researchers reveal SARS-CoV-2 distribution and relation to tissue damage in patients (2021, March 30) retrieved 15 April 2021 from https://medicalxpress.com/news/2021-03-reveal-sars-cov-tissue-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
6 shares

Feedback to editors

User comments